ウイルス学は医療システムの重要な分野の 1 つです。ワクチン開発、診断、治療療法などに幅広く応用されています。 ウイルス学市場の関係者は、市場での競争を維持するために製品の革新と開発に常に取り組んでいます。彼らは製品革新のさまざまな範囲を調査しています。たとえば、新型コロナウイルス感染症(COVID-19)に関しては、市場関係者はワクチン、検査キット、その他の関連製品やサービスの開発に多額の投資を行っています。以下は、ウイルス学市場に関連する市場動向の一部です。
- 2021 年 8 月、米国食品医薬品局 (FDA) は、ファイザーとバイオNTechの新型コロナウイルス感染症ワクチン。 ComiRNAty(コエミルナティー)として販売されます。このワクチンは、16歳以上の個人の新型コロナウイルス感染症を予防することを目的としています。緊急使用許可 (EUA) にも基づいて利用可能です。
- 2021 年 4 月、CerTest Biotec は BD MAX システム用の CE マーク付き 新型コロナウイルス感染症診断テストを開始しました。
- 5 月2020 年、バイオ・ラッドは、新型コロナウイルス感染症(COVID-19)全抗体検査の緊急使用許可について FDA の承認を取得しました。
- 2020 年 5 月、アアルト バイオ試薬は、新しい組換え真核生物 SARS-CoV-2 S1-S2 スパイク タンパク質を発売しました。
市場洞察成長低侵襲性および非侵襲性のエステティック手順の採用がウイルス学市場の成長を促進ヒト免疫不全ウイルス (HIV)、インフルエンザウイルス、ジカウイルス、エボラウイルス、SARS-CoV-2、ポリオウイルスなどのウイルスは、大規模なウイルスに感染します。世界中の人口。ウイルスが継続的に変異し進化するにつれて、薬剤耐性が人間や動物のウイルス感染管理における大きな課題となります。ウイルスは、その種類に応じてさまざまな媒体を介して感染します。たとえば、一部のウイルスはインフルエンザ、風邪、RS ウイルス感染症などの呼吸器ウイルス疾患を引き起こし、咳やくしゃみによって発生する飛沫を介して伝染しますが、一部の胃腸ウイルス疾患は感染者の糞便との直接接触によって伝染します。人や汚染された食品や水を介して感染します。 UNAIDS によると世界の HIV と感染症エイズ統計によると、2020 年には世界中で 3,770 万人以上が HIV に感染しました。
国際ウイルス分類委員会 (ICTV) は、新型コロナウイルスの原因となった新型コロナウイルスを宣言しました。 2020 年 2 月に重症急性呼吸器症候群コロナウイルス 2 (SARS-CoV-2) として -19 とされました。このウイルスは発生以来数回変異を起こしており、それが新型コロナウイルス感染症のパンデミックの深刻さをさらに増しました。たとえば、疾病管理予防センター(CDC)による新型コロナウイルス感染症追跡データによると、2021年8月の時点で、10万人あたりの7日間感染者数は299.4人で、米国では16万4,952人を超える新規感染者が報告されている。さらに、欧州疾病予防管理センターによると、2021年8月の時点で、欧州経済領域(EEA)における新型コロナウイルス感染症の総感染者数は約3,630万7,572人に達しました。したがって、このようなウイルス感染症の有病率の上昇がウイルス学市場の成長を促進しています。 タイプベースの洞察タイプに基づいたウイルス学市場はさらに、診断検査、ウイルス感染制御技術、抗ウイルス治療薬、インターフェロンに分類されます。 2021 年には、診断検査セグメントが市場で最大のシェアを握ると予想され、ウイルス感染制御技術セグメントは 2021 年から 2028 年にかけて最高の CAGR を記録すると推定されています。 < h2>ウイルス学市場、製品別 (2021 年および 2028 年)
アプリケーションベースの洞察アプリケーションベース、市場は皮膚および軟組織感染症、気道感染症、消化管感染症、性感染症、尿路感染症などに分割されています。 2021 年には、気道感染症セグメントが市場で最大のシェアを占めると推定されており、2021 年から 2028 年にかけて最高の CAGR を記録すると予想されます。
戦略的洞察ウイルス学市場で事業を展開する企業は、世界中で進化する顧客の需要を満たすための製品イノベーション戦略の採用を重視しており、これにより、世界市場でのブランド名を維持することも可能になります。 ウイルス学市場 –セグメンテーション タイプ別
- 診断テスト
- DNA ウイルス テスト
- RNA ウイルス検査
- その他
- ウイルス感染制御技術
- 積極的予防
- 受動的予防 >
- 抗ウイルス治療薬
- 殺ウイルス剤
- 抗ウイルス剤
- 免疫調節剤
- インターフェロン
- 皮膚および軟部組織の感染症
- 気道感染症
- 消化管感染症
- 性感染症
- 尿路感染症
- その他
- 病院
- 診断研究所
- 製薬会社およびバイオテクノロジー企業
- 研究機関および学術機関 >
- 北米
- 米国
- カナダ
- メキシコ
- ヨーロッパ
- フランス
- ドイツ
- イタリア
- 英国< /li>
- スペイン
- ヨーロッパのその他の地域
- アジア太平洋
- 中国
- インド< /li>
- 韓国
- 日本
- オーストラリア
- アジア太平洋地域のその他の地域
- 中東アフリカ
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- MEAの残りの部分
- 中南米
- ブラジル
- アルゼンチン
- その他のSCAM
- アボット
- ジョンソン&amp;ジョンソン サービス株式会社
- F. Hoffmann-LA Roche Ltd.
- Thermo Fisher Scientific, Inc.
- Qiagen < li>イルミナ株式会社
- シーメンス AG
- グラクソスミスクライン社 < li>Gilead Sciences, Inc.
- AbbVie, Inc.各 Web サイトに記載されている著作権名。
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Virology is a detailed study of viruses that focuses on the structure, classification, evolution, and genetics of viruses. The virology market caters to the prevention and development of treatments for several viral diseases. The increasing prevalence of emerging infectious diseases (EIDs)—chikungunya, Ebola, West Nile virus, severe acute respiratory syndrome (SARS), and Lyme disease is driving the growth of the virology market. The key driving factors for the market growth are, rising prevalence of viral infections and other infectious diseases along with growing awareness about diagnosis and treatment of the disease.
The factors that are driving and restraining factors that will affect virology market in the coming years. Factors such as rising prevalence of viral infectious diseases and increasing product launches, are driving the market growth. However, availability of alternative products and high cost of production of products are likely to hamper the growth of the market.
The virology market majorly consists of the players such as Abbott, Johnson & Johnson Services, Inc., F. Hoffmann-LA Roche Ltd., Thermo Fisher Scientific, Inc., Qiagen, Illumina, Inc., Siemens AG, GlaxoSmithKline Plc, Gilead Sciences, Inc., and AbbVie, Inc. are amongst others.
The global virology market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. North America dominates the global virology market due to factors such as technological advancement, increasing product launches, and increasing investment in healthcare and research. The transmission of infectious diseases globally has made diagnosis mandatory for travelers. Today, the diseases are spreading faster around the world, which is further bolstering the demand for diagnostic tools as they can help control the outbreak at an early stage. For instance, in September 2019, the FDA approved OraQuick Ebola Rapid Antigen Test, a new rapid diagnostic test for Ebola in the US.
Asia Pacific is expected to be the fastest growing region Asia Pacific is expected to expand at a high growth rate due to large patient population, increasing government support to provide better healthcare services, and increasing product launches by market players. For instance, in 2018, Cepheid initiated the HBDC Access Program1 for the diagnosis of HIV, viral hepatitis (HCV), and human papillomavirus (HPV)2 at a relatively lower price. The company is aiming to make tests that would be more accessible to lower-income countries.
The global virology market based on based on type is segmented into diagnostic test, viral infection controlling techniques, antiviral therapeutics, and interferons. In 2021, Antiviral Therapeutics segment is estimated to account for the largest market share in the global virology market. the growth can be attributed to increasing prevalence of human immunodeficiency virus (HIV) and increasing research and development investment by private and public companies for antiviral drugs.
The List of Companies - Virology Market
- Abbott
- Johnson And Johnson Services, Inc.
- F. HOFFMANN-LA ROCHE LTD.
- THERMO FISHER SCIENTIFIC INC.
- QIAGEN
- Illumina, Inc.
- Siemens AG
- Glaxosmithkline Plc
- Abbvie Inc.
- Gilead Sciences, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Sep 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Sep 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Sep 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Sep 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Sep 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Sep 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)